Medication info

Rosuvastatin Calcium 5 mg Oral Disintegrating Tablet

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Rosuvastatin Calcium Micronized›5.2mg / 1 tablet
Manufacturer / importer
BC World Healthcare Co., Ltd.
Appearance
White to pale yellow round orodispersible tablet
Packaging
28 tablets/box [14 tablets/PTP × 2]
Approval status
Active

MFDS item code 202107839 · Approved 2021.12.07

Summary

Main use
Improves dyslipidemia, reduces the risk of cardiovascular disease, and inhibits the progression of atherosclerosis
Who takes it
Adults · Children
Adult dose
This medicine is an orally disintegrating tablet. Place it on the tongue, allow it to dissolve, and take it without water. 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of this medicine at a dose of 40 mg is contraindicated in some of these patients.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. The safety and efficacy in children under 10 years of age have not been established.

Ingredients

Manufacturer
BC World Healthcare Co., Ltd.

Efficacy & effects

Improves dyslipidemia, reduces the risk of cardiovascular disease, and inhibits the progression of atherosclerosis

  • Hypercholesterolemia
  • familial heterozygous hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • coronary artery disease
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used as an adjunct therapy in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone do not control levels. It is also administered in conjunction with diet or other treatments to enhance effects in patients with homozygous familial hypercholesterolemia. This medication lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis, and also helps reduce cholesterol levels in certain pediatric patients with familial heterozygous hypercholesterolemia. Additionally, it is used as an adjunct in the treatment of primary dysbetalipoproteinemia and plays a significant role in reducing the risk of cardiovascular diseases, improving patient health by lowering the risks of stroke, myocardial infarction, and revascularization procedures. Overall, it is a highly effective agent for the prevention and treatment of cardiovascular diseases.

How to take

Adult dose

This medicine is an orally disintegrating tablet. Place it on the tongue, allow it to dissolve, and take it without water. 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of this medicine at a dose of 40 mg is contraindicated in some of these patients.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. The safety and efficacy in children under 10 years of age have not been established.

Precautions

This medication should not be administered to certain patients. For instance, it should not be used in patients who are allergic to its components, those with liver function issues, muscle disease patients, those taking specific medications, patients with severe renal impairment, and pregnant or nursing women. Additionally, women of childbearing potential should only take this medication if they are highly unlikely to be pregnant and fully aware of the potential risks to the fetus. High-dose administration is prohibited in patients at high risk for muscle-related disorders, such as those with moderately to severely reduced kidney function, hypothyroid patients, those with a family history of muscle disorders, and patients with alcohol dependence. This medication can affect liver function; thus, patients with a history of liver disease or excessive alcohol consumption should undergo repeat liver function tests before and during treatment. If symptoms such as myalgia, muscle weakness, or cramps occur, patients should immediately inform their doctor, undergo blood tests, and discontinue medication if necessary. Patients with acute severe conditions or specific endocrine disorders should cease using this medication. Rarely, severe muscle weakness or ocular muscle weakness can occur as a side effect, so use should be discontinued immediately if such symptoms arise. It may interact with various medications, so patients taking other medications should inform their doctor or pharmacist, especially concerning certain antiviral agents, immunosuppressants, antibiotics, and fibrate drugs. This medication may also affect kidney function, so kidney function tests should be considered at high doses. For Asian patients, drug concentrations may be higher; therefore, dose adjustments may be necessary. Pediatric and adolescent patients should be evaluated for potential effects on growth and maturation, and it exhibits a safety profile similar to that of adults. Rarely, it may cause interstitial lung disease or severe liver damage; thus, if symptoms such as dyspnea or jaundice occur, it should be discontinued immediately. Patients at risk for diabetes should regularly monitor blood glucose levels, as the risk of developing diabetes may increase; however, it is advisable to continue treatment due to the larger benefits in preventing cardiovascular diseases. Genetic factors may alter drug response, necessitating ongoing observation of treatment efficacy and side effects for dose adjustment. In case of overdose, there is no specific antidote, and symptomatic treatment and tests of liver function and muscle enzymes should be performed. Caution is advised when driving or operating machinery, as dizziness may occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container to protect from air and moisture. It is recommended to maintain a storage temperature between 1°C and 30°C. This will help preserve the medication's efficacy and safety for a longer duration.

Appearance and packaging

Appearance

White to pale yellow round orodispersible tablet

Package unit

28 tablets/box [14 tablets/PTP × 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.